CIA

Capital Impact Advisors’s Corcept Therapeutics CORT Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-26,537	Closed	-$668K	–	61
2024 Q1	$668K	Buy	+26,537	New	+$668K	0.87%	48
2022 Q1	–	Sell	-72,794	Closed	-$1.44M	–	190
2021 Q4	$1.44M	Sell	72,794 -45,290	-38%	-$897K	0.99%	37
2021 Q3	$2.32M	Hold	118,084	–	–	0.92%	45
2021 Q2	$2.6M	Sell	118,084 -50,000	-30%	-$1.1M	0.84%	50
2021 Q1	$4M	Sell	168,084 -9,216	-5%	-$219K	1.4%	21
2020 Q4	$4.64M	Hold	177,300	–	–	1.14%	29
2020 Q3	$3.09M	Hold	177,300	–	–	0.91%	36
2020 Q2	$2.98M	Hold	177,300	–	–	1%	30
2020 Q1	$2.11M	Buy	177,300 +7,312	+4%	+$86.9K	0.89%	45
2019 Q4	$2.06M	Buy	169,988 +7,444	+5%	+$90.1K	0.72%	76
2019 Q3	$2.37M	Sell	162,544 -20,926	-11%	-$305K	0.9%	24
2019 Q2	$2.04M	Sell	183,470 -10,224	-5%	-$114K	0.75%	45
2019 Q1	$2.52M	Hold	193,694	–	–	1.12%	14
2018 Q4	$2.52M	Buy	193,694 +40,705	+27%	+$530K	1.08%	15
2018 Q3	$2.1M	Buy	152,989 +35,550	+30%	+$488K	0.72%	54
2018 Q2	$1.85M	Buy	117,439 +43,141	+58%	+$681K	0.69%	59
2018 Q1	$1.22M	Sell	74,298 -3,896	-5%	-$64.1K	0.5%	108
2017 Q4	$1.41M	Hold	78,194	–	–	0.61%	77
2017 Q3	$1.51M	Hold	78,194	–	–	0.67%	54
2017 Q2	$923K	Sell	78,194 -29,956	-28%	-$354K	0.42%	125
2017 Q1	$1.19M	Buy	+108,150	New	+$1.19M	0.47%	119
2015 Q1	–	Sell	-59,735	Closed	-$179K	–	272
2014 Q4	$179K	Hold	59,735	–	–	0.08%	135
2014 Q3	$160	Hold	59,735	–	–	﹤0.01%	122
2014 Q2	$167K	Buy	+59,735	New	+$167K	0.13%	141